During the past decade, Clinical Research Institute conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 49 clinical trials were completed, i.e. on average, 83.1% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 33 clinical trials were completed. i.e. 137.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Institute" #1 sponsor was "Pfizer" with 12 trials, followed by "Meda Pharmaceuticals" with 11 trials sponsored, "Sunovion" with 11 trials sponsored, "ModernaTX, Inc." with 7 trials sponsored and "Aimmune Therapeutics, Inc." with 7 trials sponsored. Other sponsors include 56 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Institute" #1 collaborator was "Novartis" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Cephalon" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Imarc Research, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Institute" are "Asthma" (21 trials), "Migraine" (10 trials), "Perennial Allergic Rhinitis" (9 trials), "Seasonal Allergic Rhinitis" (9 trials) and "Migraine, With or Without Aura" (6 trials). Many other conditions were trialed in "Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "Clinical Research Institute" are "Drug" (77 trials), "Biological" (26 trials), "Other" (12 trials), "Device" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (48 trials), "AR101" (4 trials), "Atogepant" (4 trials), "Rimegepant" (4 trials) and "mRNA-1273.214" (4 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Institute" are 106 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Research Institute". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 85 completed trials in Clinical Research Institute, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Institute, 4 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 72 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 3 trials that are defined as “Not Applicable".